Lv4
480 积分 2023-09-08 加入
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study
29天前
已完结
Targeted therapy in BRAF mutated aggressive papillary craniopharyngioma: a case report and overview of the literature
1个月前
已完结
Prognostic Impact of Hypothalamic Perforation in Adult Patients With Craniopharyngioma: A Cohort Study
1个月前
已完结
Targeted therapies in the medical management of craniopharyngioma
1个月前
已完结
Axl as a potential therapeutic target for adamantinomatous craniopharyngiomas: based on single nucleus RNA-Seq and spatial transcriptome profiling
4个月前
已完结
Report: Successful Use of BRAF/MEK Inhibitors in Aggressive BRAF-mutant Craniopharyngioma
7个月前
已完结
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma
7个月前
已完结
Case report and literature review of BRAF-V600 inhibitors for treatment of papillary craniopharyngiomas: A potential treatment paradigm shift
7个月前
已完结
Initial Presentation of Papillary Craniopharyngioma with BRAF Mutation Treated with Adjuvant Chemotherapy (867)
7个月前
已关闭
Case report and literature review of BRAF-V600 inhibitors for treatment of papillary craniopharyngiomas: A potential treatment paradigm shift
7个月前
已完结
皖公网安备34019202002308
